Attached files
| file | filename |
|---|---|
| 10-K/A - Nuo Therapeutics, Inc. | v207277_10ka.htm |
| EX-31.2 - Nuo Therapeutics, Inc. | v207277_ex31-2.htm |
| EX-31.1 - Nuo Therapeutics, Inc. | v207277_ex31-1.htm |
| EX-32.1 - Nuo Therapeutics, Inc. | v207277_ex32-1.htm |
| EX-32.2 - Nuo Therapeutics, Inc. | v207277_ex32-2.htm |
Exhibit
23.1
CONSENT OF INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM
We hereby
consent to the incorporation by reference in the Registration Statement on
Form S-3 (No. 333-147793) and the Registration Statement on Form S-8 (No.
333-120141) of Cytomedix, Inc. of our report dated March 29, 2010, except for
the effects of the restatement discussed in Note 2 to the financial statements
as to which the date is January 7, 2011 relating to the financial
statements and financial statement schedule, which appears in this Form 10-K/A
Amendment No. 2.
/s/
PricewaterhouseCoopers LLP
McLean,
Virginia
March 29,
2010, except for the effects of the restatement discussed in Note 2 to the
financial statements as to which the date is January 7, 2011.